New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a gene mutation associated with resistance to breast cancer treatment, as well as a possible strategy for overcoming the resistance; reports encouraging results for expanding use of a new prostate cancer radiotherapy; determines the radiation level “sweet spot” for avoiding complications treating spinal tumors; and finds that proton therapy is effective against previously treated head and neck cancers.